Ombitasvir, paritaprevir, and ritonavir plus dasabuvir for 8 weeks in previously untreated patients with hepatitis C virus genotype 1b infection without cirrhosis (GARNET): a single-arm, open-label, phase 3b trial
| Image |  |
|---|---|
| Description | scientific article published on 13 April 2017 |
| Author/s |
author: Stefan Zeuzem Tami Pilot-Matias |
| Publication date | April 13, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |